Possible improved survival of patients with stage IV AJCC melanoma receiving SRL 172 immunotherapy: correlation with induction of increased levels of intracellular interleukin-2 in peripheral blood lymphocytes.
暂无分享,去创建一个
B. Baban | A. Dalgleish | P. Lydyard | A. Maraveyas | M. Jones | P. Selby | G. Rook | M. Westby | J. Grange | J. Stanford | D. Kennard